Comparison
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227 vs 3q26q28 Deletion Syndrome C6010434
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Androgens Excess and 3q26q28 Deletion Syndrome for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
A condition where an XX individual has excess male hormones causing atypical genital development. It affects both newborns and older individuals. Treatment may involve hormone management and surgical options.
3q26q28 Deletion Syndrome C6010434
A genetic condition involving deletion of part of chromosome 3q26q28, typically causing developmental delays, growth issues, and multiple congenital differences.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
0-null
3q26q28 Deletion Syndrome C6010434
Variable
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
severe
3q26q28 Deletion Syndrome C6010434
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
Chronic
3q26q28 Deletion Syndrome C6010434
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
No
3q26q28 Deletion Syndrome C6010434
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
reproductive
3q26q28 Deletion Syndrome C6010434
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
endocrine
3q26q28 Deletion Syndrome C6010434
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-androgens-excess-C5680227 and 3q26q28-deletion-syndrome-C6010434 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227 | 3q26q28 Deletion Syndrome C6010434 | Discriminating power |
|---|---|---|---|
| Genital development | Atypical genital development may occur from excess androgens in a 46,XX person. | Genital findings are not the defining feature in the supplied description. | High |
| Development and growth | Primary developmental delay or growth restriction is not established by the source. | Developmental delay, growth issues, and multiple congenital differences are typical. | High |
| Age at recognition | May be recognized in newborns or later; exact onset is not established. | Onset is variable and depends on which congenital or developmental features appear. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227 when
46,XX karyotype with androgen-related atypical genitalia
This pattern matches the endocrine category and reproductive-system focus.
High
Hormone evaluation suggests androgen excess
The source centers on excess male hormones rather than a chromosome deletion.
Moderate
No multisystem congenital pattern is described
Absence of the deletion phenotype makes the endocrine condition more plausible, but does not prove it.
Low
Choose 3q26q28 Deletion Syndrome C6010434 when
Chromosomal testing shows a 3q26q28 deletion
A confirmed deletion directly supports the genetic diagnosis.
High
Developmental delay with growth issues and congenital differences
This combination matches the supplied deletion-syndrome description.
Moderate
Features are not limited to genital development
A broader congenital pattern favors genetic evaluation over an isolated endocrine explanation.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227 | 3q26q28 Deletion Syndrome C6010434 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XX is part of the condition name. | Karyotype may be normal unless the deletion is large enough to be seen. | A 46,XX result does not exclude a microdeletion and is not itself a complete diagnosis. |
| Chromosomal microarray | No deletion is required by the source description. | May identify deletion of 3q26q28. | A confirmed deletion supports the right condition; a negative result needs specialist interpretation. |
| Androgen-related hormone tests | Results may indicate androgen excess, but no cutoff is supplied. | No characteristic hormone pattern is established. | Abnormal hormones are findings, not a diagnosis, and require clinical correlation. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
- Outcome
- Long-term outcome is not established; course is described as chronic and potentially severe.
- Factors
- Hormone findings, age at recognition, and individualized management may influence course.
3q26q28 Deletion Syndrome C6010434
- Outcome
- Outcome is variable and not quantified; developmental and congenital features may persist.
- Factors
- Deletion extent, growth, development, and associated congenital differences may matter.
Time frame: Lifelong follow-up may be needed; no specific timeline is established.
Prognosis should be based on confirmed testing and individual clinical findings, not this comparison alone.
Complications comparison
| Complication | Presentation |
|---|---|
| Genital and reproductive concerns | Atypical genital development may require specialist assessment. Reproductive effects are not established in the source. Management options mentioned for the left condition should be individualized. |
| Growth and development | Growth or developmental complications are not established. Growth issues and developmental delay are described as typical. Severity and functional impact vary and are not quantified here. |
| Multisystem congenital differences | Not described as a multisystem congenital syndrome. Multiple congenital differences may occur. Specific organ complications are not established by the supplied data. |
Patient education highlights
- HighDifferent causes
One condition involves androgen excess in a 46,XX person; the other involves missing chromosomal material at 3q26q28.
- HighTesting limits
A test result is not automatically a diagnosis. Karyotype, microarray, and hormone results need clinician interpretation.
- MediumCare planning
Both may be chronic. Care can involve endocrine, genetics, developmental, and psychosocial specialists as indicated.